Abstract
The use of charcoal hemoperfusion in the treatment of chronic renal failure has been proposed and applied by several authors. The availability of coating membranes of increased biocompatibility currently allows a safer and wider use of this purifying technique. It has been recently demonstrated that long-term treatment with combined hemodialysis/hemoperfusion yields an improvement of certain dialysis-resistant uremic signs in patients on regular dialysis treatment, while in selected patients it affords a marked reduction (up to one-third) in the overall time of treatment per week. The tolerance of long-term treatment is good. In line with these findings, a multicenter study has been carried out in Italy with two main aims: (1) to see whether long-term treatment with charcoal hemoperfusion is really safe and substantially free from side effects; (2) to verify in a larger and more varied population of patients whether such long-term treatment actually improves certain uremic signs persisting despite adequate dialysis treatment. A third phase of the multicentric study (reducing the weekly time of treatment) is currently being worked on. Five nephrology and dialysis departments took part in the study: in Bologna, Rome, Chieti, Ancona, and Lecce.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Bonomini, V., Vangelista, A., Albertazzi, A., and Stefoni, S. (1974),Proc. EDTA 11, 256.
Bonomini, V., Albertazzi, A., Bortolotti, G. C., Scolari, M. P., Stefoni, S., and Vangelista, A. (1976),Proc. 6th Int. Congr. Nephrol, Karger, Basel, pp. 680–691.
Bonomini, V., Orsoni, G., Stefoni, S., and Vangelista, A. (1979),Clinical Nephrol. 11, 275.
Bonomini, V. (1975),Kidney Int. 7, S365.
Bonomini, V., Vangelista, A., and Stefoni, S. (1978),Kidney Int. 13, S112.
Bonomini, V. (1979),Nephron 24, 157
Bonomini, V. (1981),Int. J. Artif. Organs 2, 54.
Bonomini, V., Baldrati, L., Feletti, C., Stefoni, S., and Vangelista, A. (1981), inUremia-Pathobiology of patients treated for 10 years or more, Giordano, C., and Friedman, E., eds., Wichtig, Milano, pp. 113–137.
Stefoni, S., Coli’, L., Feliciangeli, G., Baldrati, L., and Bonomini, V. (1980),Int. J. Artif. Organs 3, 348.
Stefoni, S., Coli’, L., Feliciangeli, G., Scolari, M. P., and Bonomini, V. (1981),Int. J. Artif. Organs 4, 186.
Chang, T. M. S. (1982), inHemoperfusion, Contr. Nephrol.,29, Bonomini, V., and Chang, T. M. S., eds., Karger, Basel, pp. 11–22.
Yatzidis, H. A. (1964),Proc. Eur. Dial. Transpl. Assn. 1, 83.
Dunea, G., and Kolff, W. J. (1965),Trans. Am. Soc. Artif. Organs 11, 178.
Chang, T. M. S. (1966),Trans, Am. Soc. Artif. Internal Organs 12, 13.
Chang, T. M. S., Gonda, A., Dirks, J. H., and Malave, N. (1971),Trans. Am. Soc. Artif. Internal Organs 17, 246.
Bonomini, V. and Chang, T. M. S. (1982), inHemoperfusion, Contr. Nephrol. 29.
Stefoni, S., Feliciangeli, G., Coli’, L., and Bonomini, V. (1979),Int. J. Artif. Organs 2, 230.
Andrade, J. D., Kunitoma, K., van Wagener, R., Kastigir, B., Gough, D. and Kolff, W. J. (1971),Trans. Am. Soc. Artif. Internal Organs 17, 222.
Plicchi, G., Betti, V., Canducci, G. C., Pagani, P., Rossi, M., Spighi, M., and Zingaretti, G. (1977),Policlinico Sez. Chir. 84, 37.
Bonomini, V., Stefoni, S., Vangelista, A., Nanni Costa, A., Borgnino, L. C., and Buscaroli, A. (1982),Proc. IX ESAO Meeting, Saunders, pp. 68–72.
Coli’, L., Scolari, M. P., Feliciangeli, G., Stefoni, S., and Bonomini, V. (1984), in preparation.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Bonomini, V., Stefoni, S., Feliciangeli, G. et al. Present status of hemoperfusion/hemodialysis in Italy. Appl Biochem Biotechnol 10, 157–166 (1984). https://doi.org/10.1007/BF02783748
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF02783748